可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Carols C,Pleiman CM,Gardner AM,et al. A divergence in the MAP kinase regulatory network defined by MEK kinase and raf[J].Science,1993,260:315-319.
[2]Page C,Doubell AF. Mitogen-activated protein kinase(MAPK) in cardiact issues[J].Mol Cell Biochem,1996,157:49-57.
[3]司徒镇强,吴军正.细胞培养[M],西安:世界图书出版社西安公司出版,2001.69-71,189-191,193-194.
[4] Greene EL, Velarde V, Jaffa AA. Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction invascular cells[J].Hypertension,2000,35
(4):942-947.
[5]Yang CM,Chien CS,Wang CC,et al.Interleukin-1 beta enhances bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine tracheals mooth-muscle cells:involvement of the Ras/Raf/mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK pathway[J]. Biochem J,2001,354(Pt 2):439-446.
[6] Naidu PS,Velarde V,Kappler CS,et al.Calcium-calmodulin mediate sbradykinin-induced MAPK phosphorylation and c-fos induction invascular cells[J].Am J Physio1,1999,277(3 Pt 2):H1061-H1068.
[7] Velarde V, Ullian ME, Morinelli TA, et al. Mechanisms of MAPK activation by bradykinin in vascular smooth cells[J].Am J Physiol,1999,277(2 Pt 1):C253-C261.
[8] Christopher J,Velarde V,Jaffa AA. Induction of B(1)-kinin receptors invascular smooth muscle cells.celluar mechanisms of mapkinase activation[J].Hypertension,2001,38(3 Pt 2):602-605.
[9]Yan L,Wilson DP, Warner JP,et al.Bradykinin receptor antagonists attenuate neointimal proliferation postangioplasty[J].
Am J Physiol Heart Circ Physiol,2001,281(4):H1648-H1656.
[10]蔡琪,李晓玫.丝裂原活化蛋白激酶信号转导通路研究进展
[J]. 肾脏病与透析肾移植杂志,1999,8(4):354-359.